KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to -$12000.0.

  • Arbutus Biopharma's Exchange Rate Effect fell 34000.0% to -$12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20000.0, marking a year-over-year decrease of 90000.0%. This contributed to the annual value of -$49000.0 for FY2024, which is 29600.0% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Exchange Rate Effect stood at -$12000.0, which was down 34000.0% from $21000.0 recorded in Q2 2025.
  • In the past 5 years, Arbutus Biopharma's Exchange Rate Effect ranged from a high of $44000.0 in Q3 2021 and a low of -$44000.0 during Q1 2021
  • Over the past 5 years, Arbutus Biopharma's median Exchange Rate Effect value was $1500.0 (recorded in 2023), while the average stood at -$1750.0.
  • In the last 5 years, Arbutus Biopharma's Exchange Rate Effect surged by 45000.0% in 2023 and then plummeted by 70000.0% in 2024.
  • Arbutus Biopharma's Exchange Rate Effect (Quarter) stood at $5000.0 in 2021, then crashed by 180.0% to -$4000.0 in 2022, then soared by 450.0% to $14000.0 in 2023, then tumbled by 335.71% to -$33000.0 in 2024, then surged by 63.64% to -$12000.0 in 2025.
  • Its Exchange Rate Effect was -$12000.0 in Q3 2025, compared to $21000.0 in Q2 2025 and $4000.0 in Q1 2025.